Reduced levels of human apoE4 protein in an animal model of cognitive impairment

[1]  M. Pangalos,et al.  Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels , 2008, The Journal of Neuroscience.

[2]  S. Paul,et al.  Liver X Receptor-Mediated Gene Regulation and Cholesterol Homeostasis in Brain: Relevance to Alzheimers Disease Therapeutics , 2007 .

[3]  J. Raber,et al.  Sex- and APOE Isoform-Dependent Effects of Radiation on Cognitive Function , 2006, Radiation research.

[4]  M. Hayden,et al.  The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease* , 2005, Journal of Biological Chemistry.

[5]  K. Weisgraber,et al.  Effect of Domain Interaction on Apolipoprotein E Levels in Mouse Brain , 2005, The Journal of Neuroscience.

[6]  A. Fagan,et al.  Production and characterization of astrocyte-derived human apolipoprotein E isoforms from immortalized astrocytes and their interactions with amyloid-β , 2005, Neurobiology of Disease.

[7]  C. Kelche,et al.  Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior , 2005, Behavioural Brain Research.

[8]  D. Holtzman,et al.  Human Apolipoprotein E4 Alters the Amyloid-β 40:42 Ratio and Promotes the Formation of Cerebral Amyloid Angiopathy in an Amyloid Precursor Protein Transgenic Model , 2005, The Journal of Neuroscience.

[9]  S. D. Moore,et al.  Human apoE4-targeted replacement mice display synaptic deficits in the absence of neuropathology , 2005, Neurobiology of Disease.

[10]  Judes Poirier,et al.  Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease , 2005, Neurobiology of Aging.

[11]  G. Gamkrelidze,et al.  ApoE isoform-specific effects on LTP: blockade by oligomeric amyloid-β1–42 , 2005, Neurobiology of Disease.

[12]  D. Schmechel,et al.  Marked regional differences of brain human apolipoprotein e expression in targeted replacement mice , 2004, Neuroscience.

[13]  Sung Hwan Yun,et al.  ApoE isoform affects LTP in human targeted replacement mice , 2004, Neuroreport.

[14]  CL. Wellington,et al.  Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism , 2004, Clinical genetics.

[15]  S. Paul,et al.  A liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein E expression, secretion and cholesterol homeostasis in astrocytes , 2004, Journal of neurochemistry.

[16]  L. Lanningham-Foster,et al.  Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3 , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[17]  B. Rupp,et al.  Apolipoprotein E4 Forms a Molten Globule , 2002, The Journal of Biological Chemistry.

[18]  D. Holtzman,et al.  Plaque‐associated disruption of CSF and plasma amyloid‐β (Aβ) equilibrium in a mouse model of Alzheimer's disease , 2002, Journal of neurochemistry.

[19]  Johnm . Taylor,et al.  Two Distal Downstream Enhancers Direct Expression of the Human Apolipoprotein E Gene to Astrocytes in the Brain , 2001, The Journal of Neuroscience.

[20]  B. Hyman,et al.  Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid β-peptide deposition in homozygous APPV717F transgenic mice , 2000, Acta Neuropathologica.

[21]  B. Rupp,et al.  Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain. , 2000, Biochemistry.

[22]  Kaj Blennow,et al.  Measurement of Apolipoprotein E (apoE) in Cerebrospinal Fluid , 2000, Neurochemical Research.

[23]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Charles Ramassamy,et al.  Apolipoprotein E and β-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent , 1999, Brain Research.

[25]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[26]  D. Easton,et al.  Apolipoprotein E Genetic Variation and Alzheimer’s Disease , 1999, Dementia and Geriatric Cognitive Disorders.

[27]  A. Fagan,et al.  Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. , 1999, The Journal of clinical investigation.

[28]  N. Maeda,et al.  Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. , 1998, The Journal of clinical investigation.

[29]  A. Hofman,et al.  Serum apolipoprotein E level is not increased in Alzheimer's disease: the Rotterdam study , 1998, Neuroscience Letters.

[30]  S. Paul,et al.  Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition , 1997, Nature Genetics.

[31]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[32]  Thomas Arendt,et al.  Plastic Neuronal Remodeling Is Impaired in Patients with Alzheimer’s Disease Carrying Apolipoprotein ε4 Allele , 1997, The Journal of Neuroscience.

[33]  G. Siest,et al.  Apolipoprotein (apo) E genotype and apoE concentration determine binding of normal very low density lipoproteins to HepG2 cell surface receptors. , 1996, Journal of lipid research.

[34]  T. Lehtimäki,et al.  Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls , 1996, Brain Research.

[35]  C. Finch,et al.  Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. , 1995, Brain research. Molecular brain research.

[36]  J. Poirier.  Apolipoprotein E in animal models of CNS injury and in alzheimer's disease , 1994, Trends in Neurosciences.

[37]  E. Masliah,et al.  Synaptic and neuritic alterations during the progression of Alzheimer's disease , 1994, Neuroscience Letters.

[38]  S. Gauthier,et al.  Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats , 1993, Neuroscience.

[39]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[40]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.

[41]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[42]  G. Utermann,et al.  Genetics of the apolipoprotein E system in man. , 1980, American journal of human genetics.

[43]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[44]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[45]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[46]  Edu,et al.  Molecular Neurodegeneration Apolipoprotein E Levels in Cerebrospinal Fluid and the Effects of Abca1 Polymorphisms , 2022 .